CONTINUUS to present at the NSF/NIH Bio Innovation Zone at BIO 2015

CONTINUUS Pharmaceuticals was selected to present its technology at the 2015 BIO International Convention in Philadelphia during June 15-18.  CONTINUUS will showcase its work at the NSF/NIH Bio Innovation Zone, which has been funded by a Phase I SBIR grant from the NSF.  CONTINUUS was also one of twelve companies chosen to present/pitch their stories, pipelines, and objectives to all attendees.

Comments are closed.